ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Age Doesn’t Affect Survival After Bone Marrow Transplant

December 26, 2008

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

In Brief: Newell Tells Advisory Committee It Isn’t a Lobbying Group, “Accept What We Give You”

April 8, 1977

December issue of Business & Regulatory Report included (an additional 8 pages of industry news).

December 10, 2004

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

ASCO Teleconference Set For Nov. 12

October 31, 1986